Abstract:Objective To investigate the feasibility, safety and efficacy of transarterial embolization with low concentration of n-butyl cyanoacrylate(NBCA) in rabbit VX2 liver tumor models. MethodsTwenty-four rabbits were implanted with VX2 hepatic tumors into the left hepatic lobes, and were scanned with CT to measure the volume of the tumor after 14 days. They were randomly divided into three groups with 8 rabbits assigned to each group. Transarterial embolization was conducted with physiological saline in control group A, with pure Lipiodol in group B, with 2.5% NBCA in group C. Hepatic toxicity was evaluated by blood biochemical analysis of the plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST). One week later, the volumes of the tumors were measured by CT again. Tumor growth rate was the ratio of tumor's volume at 7th day after embolization to the tumors' volume before embolization. The survival periods of the rabbits of the three groups after treatment were also recorded. The data of ALT and AST mean values from each group were analyzed with repeated measurement analysis of variance (ANOVA). Tumor growth rates and survival periods were analyzed by using one-way ANOVA. Results All animal models were successfully established and underwent interventional catheterization. Both ALT and AST mean values of the rabbits in group A, B and C at each time point before and after embolization were significantly different (ALT F=10.508, 16.443, 19.828, respectively; AST F=23.696, 23.334, 15.594, respectively)(P＜0.05). ALT in group A, B, C were (49.4±13.5), (115.2±48.8), (124.7±49.4)U/L, while AST in group A, B, C were (52.3±12.0), (128.3±50.1), (137.0±66.9)U/L 4 days after embolization. The ALT and AST mean values were significantly elevated 4 days after embolization in group B and group C compared with those before embolization and those of group A 4 days after treatment(P＜0.05). However, the ALT and AST mean values showed no statistically significant difference in all the groups before embolization and 7 days after embolization. On the other hand, the growth rates of the tumors differed significantly among the three groups(F=110.865, P=0.000). The group C showed significantly lower tumor growth rate (0.839±0.144)% than the group A(2.978±0.547)%(P=0.000), but no significantly different tumor growth rate compared with group B(0.871±0.0725)%( P=0.845). Consequently, the survival period of the animals in group C(38.9±4.0) days was significantly longer than that in group A(32.1±3.1)days (P=0.006), while it was not significantly different from that in group B(36.9±4.8)days(P=0.366). ConclusionsTransarterial embolization with low concentration of NBCA was feasible and safe. It could be a new option of treatment for HCC and might have potential further clinical value.

Transcatheter Arterial Embolization Followed by Octreotide and Celecoxib Synergistically Prolongs Survival of Rabbits with Hepatic VX2 Allografts.

Octreotide and Celecoxib Synergistically Encapsulate VX2 Hepatic Allografts Following Transcatheter Arterial Embolisation

Targeting metabolic reprogramming promotes the efficacy of transarterial chemoembolization in the rabbit VX2 liver tumor model

Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer after Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model

Transcatheter Arterial Embolization Combined with Radiofrequency Ablation Activates Cd8(+) T-Cell Infiltration Surrounding Residual Tumors in the Rabbit Vx2 Liver Tumors

Study on peritumoral anti-angiogenesis of hepatic VX2 tumor by transcatheter arterial chemoembolization combined with Sorafenib ultrasound microbubbles in rabbits

The therapeutic effect of low frequency ultrasound mediated microbubbles destruction on rabbit VX2 orthotopic hepatic tumors

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Efficiently Inhibits Growth of VX2 Cells and VX2 Tumor Model of Hepatocellular Carcinoma in Rabbit by Transarterial Embolization-Mediated Sirna Delivery.

Radiofrequency Ablation Combined with Transcatheter Therapy in Rabbit VX2 Liver Tumors: Effects and Histopathological Characteristics

TACE combined with endostatin for the treatment of rabbit VX2 hepatic carcinoma:an analysis of the correlation between CT perfusion parameters and tumor angiogenesis

Transcatheter Hepatic Artery Infusion with Recombinant Human Endostatin Combined with TACE for Rabbit VX2 Hepatoma and Evaluation on Angiogenesis by CT Perfusion

[Influence of As2O3-lipiodol Emulsion Via Transarterial Embolization on a VX2 Liver Tumor Model in Rabbits].

Combined therapy of radiofrequency ablation with transcatheter artery embolization in rabbit model of hepatic carcinoma

Effects of transcatheter arterial chemoembolization on growth and metastasis of rabbit VX2 hepatic tumor

CTA Combined with CT Perfusion for Assessing the Efficacy of Anti-Angiogenic Therapy in Rabbit VX2 Tumors.

Abstract No. 28: Transarterial Embolization with Low Concentration of N-Butyl Cyanoacrylate in VX2 Hepatic Tumor Rabbit: an Experimental Study

[Transcatheter Arterial Chemoembolization with High-Dose Iodized Oil for Hepatic VX2 Tumor in Rabbits].

Alginate-barium Sulfate Microspheres Via Vascular Interventional Procedures in Treatment of VX2 Tumor-Bearing Rabbits

Evaluation of Hepatic Blood Flow Alteration in Celecoib Combined with TAE Treated Liver Vx2 Tumor Rabbits

Effect of transcatheter arterial chemoembolization together with radiofrequency ablation on VEGF and MVD in rabbit models with hepatic cancer

Hepatic Arterial Embolization with Glycolic Acid-Ethylcellulose Microspheres in Treatment of Hepatic Tumor in Rabbits